Skip to content

Comparison of Perioperative Outcomes of Three Different Instruments in Total Laparoscopic Hysterectomy

Comparison of the Use of LigaSure, Halo PKS Cutting Forceps and Enseal Tissue Sealer in Total Laparoscopic Hysterectomy: a Randomised Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01745315
Enrollment
45
Registered
2012-12-10
Start date
2013-02-28
Completion date
2013-06-30
Last updated
2013-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Outcomes

Keywords

total laparoscopic hysterectomy, LigaSure, EnSeal, Halo PKS Cutting forceps, electrothermal bipolar vessel sealer, advanced bipolar device

Brief summary

There are many instruments with different energy modalities or with different properties that are available for use in total laparoscopic hysterectomy. The aim of the present study is to compare three of these instruments that are present in our clinic - HALO PKS Cutting Forceps, LigaSure and Enseal Tissue Sealer, in total laparoscopic hysterectomy with respect to operation time, blood loss, change in hemoglobin / hematocrit levels, perioperative complications, return of gastrointestinal activity and hospitalization time.

Interventions

DEVICEAdvanced bipolar devices

Sponsors

Adana Numune Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* any women with the indication of hysterectomy

Exclusion criteria

* malignancy * having 3 or more previous abdominal surgeries * uterus being larger than 12 weeks of gestation * patients who must undergo additional surgical procedures during the same operation

Design outcomes

Primary

MeasureTime frameDescription
Perioperative OutcomesUntil 45 patients are operated (6 months anticipated)Perioperative outcomes will be assessed with respect to complication rates, operation time, blood loss, change in hemoglobin and hemotocrit levels, time to return of gastrointestinal function and hospitalization time.

Countries

Turkey (Türkiye)

Contacts

Primary ContactHakan Aytan, Associate Professor, M.D.
drhakanaytan@yahoo.com+905056833866

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026